Literature DB >> 11735132

Reactive oxygen species in mechanical stress-induced cardiac hypertrophy.

R Aikawa1, T Nagai, M Tanaka, Y Zou, T Ishihara, H Takano, H Hasegawa, H Akazawa, M Mizukami, R Nagai, I Komuro.   

Abstract

Mechanical stress induces various hypertrophic responses including activation of mitogen-activated protein kinases (MAPKs) in cardiac myocytes. Here we examined the role of the small GTP-binding proteins of Rho family and reactive oxygen species (ROS) in stretch-induced activation of p38MAPK in cardiomyocytes. Overexpression of dominant-negative mutants of Rac1 (D.N. Rac1), D.N.RhoA and D.N.Cdc42 suppressed stretch-induced activation of p38MAPK. Overexpression of constitutively active mutants of Rac1 (C.A.Rac1) and C.A.Cdc42 increased the p38MAPK activity in the absence of mechanical stress. Pretreatment with N-acetyl-L-cysteine and N-(2-mercaptopropionyl)-glycine (NAC) suppressed stretch-induced activation of p38MAPK. Mechanical stretch increased intracellular ROS generation, which was abrogated by overexpression of D.N.Rac1 and attenuated by overexpression of D.N.RhoA and D.N.Cdc42. An increase in protein synthesis evoked by mechanical stretch was suppressed by overexpression of D.N.Rac1 and pretreatment with NAC. These results suggest that mechanical stress induces cardiac hypertrophy through the Rac1-ROS-p38MAPK pathway in cardiac myocytes. (c)2001 Elsevier Science.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11735132     DOI: 10.1006/bbrc.2001.6068

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  25 in total

Review 1.  Integration of pathways that signal cardiac growth with modulation of myofilament activity.

Authors:  R John Solaro; David M Montgomery; Lynn Wang; Eileen M Burkart; Yunbo Ke; Susan Vahebi; Peter Buttrick
Journal:  J Nucl Cardiol       Date:  2002 Sep-Oct       Impact factor: 5.952

Review 2.  Role of Rac1-mineralocorticoid-receptor signalling in renal and cardiac disease.

Authors:  Miki Nagase; Toshiro Fujita
Journal:  Nat Rev Nephrol       Date:  2013-01-08       Impact factor: 28.314

Review 3.  Drosophila models of cardiac disease.

Authors:  Nicole Piazza; R J Wessells
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

4.  Multiple measures of functionality exhibit progressive decline in a parallel, stochastic fashion in Drosophila Sod2 null mutants.

Authors:  Nicole Piazza; Michael Hayes; Ian Martin; Atanu Duttaroy; Mike Grotewiel; Robert Wessells
Journal:  Biogerontology       Date:  2009-01-16       Impact factor: 4.277

Review 5.  Regulation of cell survival and death by pyridine nucleotides.

Authors:  Shin-Ichi Oka; Chiao-Po Hsu; Junichi Sadoshima
Journal:  Circ Res       Date:  2012-08-17       Impact factor: 17.367

Review 6.  Cyclic stretch, reactive oxygen species, and vascular remodeling.

Authors:  Konstantin G Birukov
Journal:  Antioxid Redox Signal       Date:  2009-07       Impact factor: 8.401

7.  Integrating GRK2 and NFkappaB in the Pathophysiology of Cardiac Hypertrophy.

Authors:  Daniela Sorriento; Gaetano Santulli; Antonietta Franco; Ersilia Cipolletta; Luigi Napolitano; Jessica Gambardella; Isabel Gomez-Monterrey; Pietro Campiglia; Bruno Trimarco; Guido Iaccarino; Michele Ciccarelli
Journal:  J Cardiovasc Transl Res       Date:  2015-07-30       Impact factor: 4.132

Review 8.  The role of redox modulation of class II histone deacetylases in mediating pathological cardiac hypertrophy.

Authors:  Shin-ichi Oka; Tetsuro Ago; Takanari Kitazono; Daniela Zablocki; Junichi Sadoshima
Journal:  J Mol Med (Berl)       Date:  2009-05-08       Impact factor: 4.599

9.  Biomechanical signals upregulate myogenic gene induction in the presence or absence of inflammation.

Authors:  Ravi Chandran; Thomas J Knobloch; Mirela Anghelina; Sudha Agarwal
Journal:  Am J Physiol Cell Physiol       Date:  2007-03-28       Impact factor: 4.249

10.  Foxo3a inhibits cardiomyocyte hypertrophy through transactivating catalase.

Authors:  Wei-Qi Tan; Kun Wang; Dao-Yuan Lv; Pei-Feng Li
Journal:  J Biol Chem       Date:  2008-09-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.